|
HS Code |
963883 |
| Productname | 3-Bromo-5-Fluorinazole |
| Molecularformula | C7H4BrFN2 |
| Molecularweight | 215.03 g/mol |
| Casnumber | 885273-79-8 |
| Appearance | Off-white to pale yellow solid |
| Purity | Typically ≥ 97% |
| Solubility | Soluble in DMSO, slightly soluble in water |
| Synonyms | 3-Bromo-5-fluoro-1H-benzimidazole |
| Smiles | Brc1cc(F)nc2[nH]ccc12 |
| Storagetemperature | 2-8°C |
As an accredited 3-Bromo-5-Fluorinazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-5-Fluorinazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Let’s talk about why certain molecules get handed a spot on the chemist’s workbench time and again. 3-Bromo-5-Fluorinazole is one of those names that keeps showing up when people want selectivity and reliability in synthesizing pharmaceuticals, agrochemicals, and specialty materials. As someone who’s spent more late nights under fume hoods than I’d care to count, it’s easy to see why this compound has become such a draw for industry and academia. Its structure allows for unique substitution patterns and functionalization—something not so easy to pull off with every halogenated azole in the catalog.
With a molecular formula of C3H2BrFN2, 3-Bromo-5-Fluorinazole carries both bromine and fluorine atoms on the aromatic ring. This combination matters when it comes to fine-tuning reactivity. The azole core itself sits at the intersection of nitrogen-rich heterocycles—systems prized for their electronic and hydrogen bonding properties. Toss in the bromine at position 3 and the fluorine at position 5 and chemists get a handle for cross-coupling or nucleophilic substitution reactions. Sudden breakthroughs in synthesis don’t just happen. Building blocks like these are what let folks make precision molecules without dragging through too many tedious steps.
Some people may ask why labs go to the trouble of working with advanced intermediates at all. Can’t you just start with basic azoles and scale up? In my experience, the reason is complexity. Modern pharmaceuticals aren’t built on a simple backbone. Drug designers now focus on bioisosteres—structural tweaks that make a molecule more potent or less likely to break down too soon in the body. That’s where halogen atoms on the azole ring do their heavy lifting. Bromine brings solid leaving group ability, which makes it possible to swap in whole new side chains. Fluorine can adjust the acidity or lipophilicity—tricks that help control how a molecule gets absorbed and moves through living tissue. It’s not just about piling on atoms. The placement here means the difference between getting a candidate to clinical trials or heading back to the drawing board.
Development teams at pharma companies know that breakthroughs demand more than academic theory. What’s interesting about 3-Bromo-5-Fluorinazole is how many types of molecules it can help build. Heterocycles with both bromine and fluorine appear in antifungals, antihistamines, and even next-generation herbicides. Some folks use it as a late-stage intermediate to anchor important functional groups. For example, Suzuki cross-coupling opens up access to chiral side chains or complex aromatic systems. Other times, it’s a stepping stone towards more elaborate nitrogen heterocycles—imatinib and similar kinase inhibitors, for example, rest on smart choices during intermediate construction.
Anyone in the lab learns quickly that stability counts for a lot when it’s time to move from benchtop to pilot scale. Out of all the azole derivatives I’ve worked with, those carrying both bromine and fluorine tend to behave better during longer synthetic runs. 3-Bromo-5-Fluorinazole holds up well under most storage conditions, provided moisture stays low. Sure, basic chemical hygiene applies—well-sealed containers, attention to ventilation, nitrile gloves. The absence of particularly reactive functional groups makes it easier to use compared to some of the more temperamental bromo- or fluoro-compounds. Less time fighting with decomposition means more time plotting the next step in the synthesis.
Go through any catalog of nitrogen heterocycles and you’ll notice plenty of fluorinated or brominated entries, though rarely with this specific substitution pattern. Placing a bromine at position 3 and a fluorine at position 5 brings a level of regioselectivity that general-purpose azoles can’t match. For teams designing new inhibitors or probes, this translates to controllable reactivity. I’ve seen projects shift entirely because an intermediate offered the right handle for a late-stage introduction of a bulky group or a solubilizing moiety. Comparing with other brominated azoles, those without the fluorine often lack the same metabolic stability. On the other hand, fully fluorinated azoles can get too unreactive or too expensive. This middle ground delivers most of the value at a manageable price-point.
In the wake of global raw material shortages, companies keep a sharper eye on availability. Ten years ago, getting specialized building blocks like this often meant delays, especially if import barriers cropped up. The last few supply crunches forced labs to either keep deep inventories or switch to intermediates that show up on schedule. 3-Bromo-5-Fluorinazole fits into the newer trend of intermediates produced at industrial scale, backed by predictable quality control. I’ve encountered fewer headaches over batch variability with this material. Most reputable suppliers now list HPLC purity over 98%, which takes some risk out of multi-step synthesis planning.
Any chemist will remind you that brominated compounds have their fair share of safety flags. While this intermediate is easier to handle than some of the more volatile relatives, it still pays to treat it with a healthy respect. Transparent material safety information and clear hazard labeling go a long way. The best suppliers share details on reactivity, compatibility, and recommended decontamination methods. Personally, I stay vigilant about disposal—halogenated waste can turn into a regulatory headache if it piles up. Most operations rely on in-house neutralization tanks or trusted hazardous waste services. Taking shortcuts with chemical safety never amounts to real productivity gains in the long haul.
There’s no shortage of hype in the world of molecule-building, but real results come from precise design choices. Inclusion of both a bromine and a fluorine atom at strategic positions on an azole ring lets chemists fine-tune not just yields, but the integrity of the final compound. With the pharmaceutical industry putting increased scrutiny on off-target effects and metabolic profiles, more researchers turn to these dual-substituted azoles to customize pharmacokinetics. In my lab days, swaps between mono- and di-substituted versions often made the difference between patentable novelty and a failed lead. 3-Bromo-5-Fluorinazole continues to be one of those smart investments because it gives you more than one pathway toward the target molecule.
There are few synthetic methods in organic chemistry as versatile as palladium-catalyzed cross-coupling. If you want to walk into a room full of process chemists and catch their attention, talk specifically about how a molecule like 3-Bromo-5-Fluorinazole streamlines these reactions. Its bromine atom is reactive enough to participate efficiently, cutting down on catalyst consumption and troublesome byproducts. I’ve seen projects that would have needed an extra protection-deprotection cycle short-circuited thanks to this compound’s selectivity. The presence of fluorine helps nudge the electronic character of the azole, so chemoselectivity becomes less of a gamble. That plays directly into higher yields and fewer purification headaches—a win for both cost and timeline.
Not long ago, sustainability in fine chemicals grew out of regulatory arm-twisting. Today, most organizations put some real thought into reducing waste and minimizing risk. Here’s what’s meaningful about 3-Bromo-5-Fluorinazole: it’s often prepared via routes that avoid heavy metal reagents and keep side product profiles manageable. In-house comparisons show that batch processes involving this intermediate leave a lighter footprint on effluent treatment plants. Labs looking to up their green chemistry game find it simpler to meet emission controls while keeping synthetic flexibility on the table. I’ve seen teams score big on internal sustainability audits simply by swapping less predictable intermediates for more reliable, selective compounds like this one.
For most product development cycles, cost-per-gram matters, but not at the expense of predictability or regulatory standing. With fluorinated and brominated building blocks, the sweet spot lies somewhere between niche novelty and generic commodity. What stands out for 3-Bromo-5-Fluorinazole is how it threads that needle. Teams with tight schedules appreciate suppliers who can turn over lot-specific analytical data before shipment. The compound’s broad adoption among contract manufacturing organizations means more competitive pricing—without the risk of supply roulette. For startups and university labs, that keeps projects on track without having to call in favors or fast-track procurement at a premium.
Compliance moves at an inconsistent pace, especially when it comes to evolving guidelines around halogenated compounds. The pharmaceutical and agrochemical sectors face regular updates around safe handling, acceptable impurities, and environmental impact. Over the last few years, 3-Bromo-5-Fluorinazole has established a track record that aligns with current standards in the main jurisdictions—making life easier for quality and regulatory staff. Its presence in peer-reviewed synthetic schemes and process patents provides confidence when drafting technical packages for drug master files or new chemical entity dossiers. I’ve seen regulatory filings move faster thanks to the stable impurity profiles and reproducible process data available for this product. That’s not always the case with less mainstream heterocyclic intermediates.
No good intermediate stops at a single class of products. A quick scan of recent literature shows teams using 3-Bromo-5-Fluorinazole to branch into photonic materials and specialty polymers. Research groups keep looking for azole-derived monomers that pass both thermal and oxidative stress tests. The electronic properties unlocked by introducing both bromine and fluorine make it a candidate for next-gen optoelectronics and chemical sensors. Despite the rush towards automation and AI-driven reaction planning, chemists still depend on time-tested intermediates when pushing the edge of new material science. In seminars, I’ve heard from teams who credit uniquely substituted azoles with unexpected boosts in device stability or charge transfer. Laboratory curiosity often seeds true innovation in unexpected directions.
What makes productive chemistry isn’t just better molecules, but better networked people. Across industries, adoption of 3-Bromo-5-Fluorinazole often sparks collaboration. Research consortia share methodology toolkits and reaction optimization charts, making it easier for junior chemists to find better routes. Community-contributed databases list common side reactions and best-performing catalysts—helpful data points that cut the guesswork in half. I’ve seen big wins arise when synthetic scale-up teams debrief about stumbling blocks in highly substituted azole syntheses. The more the community collects and shares feedback—warts and all—the faster and safer the learning curve for everyone. That’s not something you can automate or outsource.
Talking about high-value intermediates often means describing incremental improvements: higher yield here, better purity there, a few less headaches all around. But anyone who builds multi-step synthetic pathways knows these small gains add up. 3-Bromo-5-Fluorinazole isn’t the flashiest addition to a development pipeline, yet it represents the kind of hard-earned progress that makes ambitious research programs possible. No overhauls needed, just small deliberate steps—cutting out unnecessary purifications, dialing in the right balance of reactivity and selectivity, and meeting tighter deadlines with fewer surprises. Teams looking to bring new medicines or smarter materials to market see the difference these incremental improvements make. I’ve come to appreciate this compound not because it reinvents the wheel, but because it keeps projects rolling along smoother, safer, and just a little bit faster.
Sure, every chemist starts out mixing reagents and learning the shape of glassware, but understanding why certain intermediates matter takes a different kind of learning. In training environments, 3-Bromo-5-Fluorinazole is a case study in strategic substitution: how placement of different halogens on an azole ring influences reactivity and downstream biological activity. In my teaching days, I saw students struggle with the jump from textbook schemes to real substrates with quirks and contaminant profiles. Using approachable, reliable intermediates builds confidence and establishes good technique. It also teaches respect for both the hazards and the opportunities that real chemical building blocks bring to the table.
More than ever, pharmaceutical and agrochemical pipelines need flexibility and speed. Intermediates that can take the heat—literally and figuratively—are in high demand. 3-Bromo-5-Fluorinazole’s track record in diverse coupling reactions makes it a go-to option for fast, modular assembly of new lead compounds. Having spent time in process development, I’ve seen how a bottlenecked step can stall an entire program. Relying on an intermediate that responds predictably across different scales means fewer fire drills and emergency retrosyntheses. These are the less glamorous details that keep pharmaceutical timelines on course, without sacrificing the creative leaps that lead to first-in-class treatments.
Every chemist appreciates an intermediate that grants more options than it takes away. For scale-up specialists, 3-Bromo-5-Fluorinazole rarely needs dramatic process re-engineering. Whether the route relies on classical thermal reactions or exploits the latest in flow chemistry, this compound’s compatibility with standard reagents gives wide leeway for process innovation. Handling routines for this molecule can be integrated into existing plant protocols, while minor tweaks help maximize throughput or cut down on solvent use. I’ve watched teams shave weeks off development by switching to intermediates that play nice with automation and remote monitoring—key trends shaping the future of chemical production.
Moving from research to commercial production always comes with hurdles—supplier qualification, logistics, and consistent documentation. Today’s landscape offers more transparency and more reliable partnerships. Industry standards for lot certification, impurity analysis, and sustainability metrics continue to evolve. Companies sourcing 3-Bromo-5-Fluorinazole can expect detailed product dossiers and full traceability, which cuts down on surprises. In my experience, building strong supplier relationships pays off—on-time delivery, routine technical updates, and direct feedback channels make scaling up or pivoting to new derivatives much less painful.
For all its niche appeal, 3-Bromo-5-Fluorinazole chips away at the everyday challenges that define modern chemical synthesis. Its resilience, adaptability, and proven track record make it the kind of molecule worth investing in for the long haul. I’ve watched project milestones get met more consistently, safety reviews run smoother, and process audits conclude with fewer loose ends. As teams chase both greater complexity and cleaner, greener chemistry, intermediates like this one help bridge the old with the new. There’s a quiet value in having trusted building blocks, and this azole derivative fits that mold.